{"name":"Eleusis Therapeutics","slug":"eleusis-therapeutics","ticker":"","exchange":"","domain":"","description":"Eleusis is a pharmaceutical company that is developing serotonin 5-HT2A receptor agonists related to serotonergic psychedelics as novel anti-inflammatory drugs to treat inflammatory diseases. It is interested in developing the drugs for treatment of conditions like asthma, cardiovascular disease, and Crohn's disease, but is initially focusing on ophthalmology.","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQa1EzVDFkU3FmY1VUajZ6ZXhnVnBNTjdURXNES3dsRVpYNDlRU1dweUg1Y3lIZ2ZueDhsTFo2anE2dHIyeHhFX1NDUU5pdUtBV3VFdl9vOUNCcU9NejhKZUJnY21jdy1ISFNrYWxYSlVWZl9kX1l1c2hVdUZfVlhaSUtWTDM4MHBzbTFiU3lBdFRDQkkz?oc=5","date":"2026-04-06","type":"trial","source":"openPR.com","summary":"Allergic Conjunctivitis Clinical Trials Landscape 2026: - openPR.com","headline":"Allergic Conjunctivitis Clinical Trials Landscape 2026:","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxOOGtzUHNmN0hwalJEWHY5a0xxT0d6ajNSWU9DZTQ0Y2p0Z2piSExIN0pYTmNMUS14YWx2WmpUVVA0ekVyejlKc2diRHdSd3VFTW5MbUlTN3FKSzc4STJFenA5R1RLbDY2MUhSLVZrUjkyUXRPUXR5VXUzR2wxOVBjOWNaVmpRVVVjLTZhdEJHSjNfSmJwVFpPM0p1aFVhWU9yWmNvaXRFOWd1aUpY?oc=5","date":"2025-06-09","type":"pipeline","source":"Medscape Reference","summary":"Addressing Partial Treatment Response in MDD Patients - Medscape Reference","headline":"Addressing Partial Treatment Response in MDD Patients","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxOLVQ0Unh3Sk9nZmxCWkxSMWw2NE5EVUUzU2h1bnlYV1Jmc0lud09RN1NSaldhLUxKUXcxZDdZTlRBRS1kODFjQ0x2MEMtdHFpTXIyQ0U5YVAyOU02Y0pFRTBjZlFXZExuVFE4N2cxUkxRbTZkM1NnbEZKVFRPd0Fta2piUnQxamMzblFqYkNrSXAxMDdMNWVYbGNhbUZUZzc2dVVxTHh3eU00WGpCMm9PdXdTenpqZTVGQktxeWZlX0xRQ2dtTUt1U0xTbHByS19zOExibTcxRzlBZWtDSnVTOXhXUVRZV1BIMmFZ?oc=5","date":"2024-03-13","type":"pipeline","source":"GlobeNewswire","summary":"Global Psychedelic Drugs Market Size To Worth USD 8.7 Billion By 2033 | CAGR of 11.61% - GlobeNewswire","headline":"Global Psychedelic Drugs Market Size To Worth USD 8.7 Billion By 2033 | CAGR of 11.61%","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMicEFVX3lxTFBRNmp6dmtCUWlZbW92RjI1c3F5amI1U0xpTUdPaEpuLTFjSzBYTUg5TlBkUU5vZ2k0bm9BcnFsZVpOZE5mY3hPb2oydG9IVlVoc2ZGM2liOXFZZS1raXhabThBY21OWURHczd0Nm01bmY?oc=5","date":"2023-02-21","type":"pipeline","source":"nuwireinvestor.com","summary":"PsychedelicScape 2023: Psychedelic Companies Building the Future - nuwireinvestor.com","headline":"PsychedelicScape 2023: Psychedelic Companies Building the Future","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxQN25NUE1ueWE3ai1fZFRjMURlYmhkaDRoYWUySUtGQjNoTXgwdlZUZ0p0UHJDaW1GTEVtc0RDelM1RmpHbF9RNFRFRW5fU0tMU3d0dWhlRE1rRWsxbktCTGFpWVVPU1JsS0Y0UnlYOG5vNnA3Rmg0VFRaaGZfSDRxd1FuRmd5RUVlZk5CcTdNSDE3enY3M1dQVm93aGY0Q1FzWEo5NlV1S2pHdjQyYW5MREluZnZjd3BtWTJOUG9JelVGc1FCc2lJ?oc=5","date":"2022-11-07","type":"deal","source":"Healio","summary":"Beckley acquires Eleusis, strengthening pipeline of psychedelic-based therapeutics - Healio","headline":"Beckley acquires Eleusis, strengthening pipeline of psychedelic-based therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxPSDd3MmdUQ2tRUXZ5dl9mNmpTVld4eWhWN0Z6cmY0c05ES0Z4anVjSzl1MzdNVVloR0czSGlzUU9POExSQUhVUGctbzZsTmE0bFRFaHJNVGhhUjNMOEJqVU10SDF3X2pXbW5KMkVaMk9aMDRDd0RvcFVIV1d3VlhxMk5Fb2hTVkd4bFRCbU5KaEl0Rlk0YWo0bA?oc=5","date":"2022-10-26","type":"patent","source":"BioWorld News","summary":"Protagonist Therapeutics patents new SLC40A1 ligands - BioWorld News","headline":"Protagonist Therapeutics patents new SLC40A1 ligands","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOelliUW56R1prN1B6SkZWNnZMVDVjT1VfcU1aMDFDZzhxRk1wVWxJWE1oc0R2UHU5ZUhVemplaVBtTzhpVkItZ1JqZXFmRl8yN0xHZzRLalc3dm56TWxtYnQ0VHZ2SGkzcFlqdk5lZHQ1bW51QTN0RmE4eHNkWkpQLUV2UnRVN3RNdHl3?oc=5","date":"2022-10-24","type":"deal","source":"Labiotech.eu","summary":"Beckley Psytech acquires Eleusis Therapeutics - Labiotech.eu","headline":"Beckley Psytech acquires Eleusis Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxOeFhvY2pQTGRXaUVla0MyU256YzlTdm1rM3JNZzg2a00zdTVRM3Z6VmRKeHVlQkZHLTBaVUFXTWttcGdqWnJVR3pUSDVrNE9vempYSERwSFdXb3AzMWI1XzZqS29aWTRGMzUtTHlIMEEyM0FpbUtfTURYTHBMeE81QWpLNjBtMS1wZl9wdWJfNDRtUWhSNDFTQndvWnh3eGhQYm5LbEJ5dlZSMnliZ1d4TTNvQ1pUVTlCdGdaME5lb1dheXBOekJZXw?oc=5","date":"2022-01-20","type":"pipeline","source":"Fierce Biotech","summary":"Eleusis joins cooled-off SPAC market with $288M to bankroll psychedelic-based depression drug - Fierce Biotech","headline":"Eleusis joins cooled-off SPAC market with $288M to bankroll psychedelic-based depression drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxORVV1ZzdXaDh3bG9fa3BNajVVejRWRFZZUkYtMzdjNU5ybEtMY0NVSk1BWnlmLWRrRDRGRDc2aDBhLTkzSnoyekxSRFlXNUZnNm1QdGI5cUNqblh0VHRiMm02NnAyck81VmdIR01wd0VQY2pOSGVpNEt4NjU5cFF3VDdiTWZWbkVjNzFJSC03LXpkQ1NCV2Y4c0dmUnI2QjRIelRpRnR6bllzZw?oc=5","date":"2020-05-06","type":"pipeline","source":"Business Insider","summary":"Meet the top 9 startups raising millions to use psychedelics to treat depression, anxiety, and more - Business Insider","headline":"Meet the top 9 startups raising millions to use psychedelics to treat depression, anxiety, and more","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxPakNCWVhkZTRGWmQyOUg3WnB5TnhMOER4VEQ2Vmo3OHI4T0JKWURTemtXUk9PVTllRG9sSjdTWG1uR3FiTzFjWUQ0dmdTQVlncG5rUmhacUpkbXJZRmpoVnp6a0FueTR0YmMtVFBmVXlKY3VxTnd3c0c4dGx0RUg5X3VDeHp1cWpaaVdBUGVxTDI4dw?oc=5","date":"2019-12-19","type":"trial","source":"Pharmafile","summary":"LSD treatment for Alzheimer’s patients proves safe in recent trial - Pharmafile","headline":"LSD treatment for Alzheimer’s patients proves safe in recent trial","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}